Tango Therapeutics, Inc. · NASDAQ:TNGX
Goldman Sachs Group Inc reported a 6.00% stake in Tango Therapeutics, Inc. (Schedule 13G)
Event Jun 30, 2026 · Filed Aug 14, 2026
Goldman Sachs Group Inc reported a 6.00% stake in Tango Therapeutics, Inc., 9,742,403 shares, as a passive investor on Jun 30, 2026. Filed Aug 14, 2026 (Schedule 13G).
- Stake
- 6.00%
- Shares
- 9,742,403
- Intent
- Passive
- What changed
- Crossed above 5%
- Filed together
- 2 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| THE GOLDMAN SACHS GROUP, INC. | 6.00% | 9,742,403 |
| GOLDMAN SACHS & CO. LLC | 6.00% | 9,742,403 |
Source
Related
- Tango Therapeutics, Inc.
- Goldman Sachs Group Inc
- Tango Therapeutics, Inc. shareholders
- Form 4 · Crystal Adam · Oct 5, 2026
- Form 4 · Newcomb Jessica · Sep 24, 2026
- Form 4 · Crystal Adam · Sep 3, 2026
- Schedule 13G/A · TCG Crossover GP II, LLC · Aug 14, 2026
- Schedule 13G/A · Nextech Crossover I GP S.a. r.l. · Aug 14, 2026